<s id="wsj_1594.1"> 9
1 	 0 	 N/N 	 1 	 companies Health-care
1 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 companies should
1 	 3 	 (S[b]\NP)/(S[adj]\NP) 	 1 	 companies get <XB>
1 	 4 	 S[adj]\NP 	 1 	 companies healthier <XB>
3 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 get should
3 	 5 	 ((S\NP)\(S\NP))/NP 	 2 	 get in
4 	 3 	 (S[b]\NP)/(S[adj]\NP) 	 2 	 healthier get
8 	 5 	 ((S\NP)\(S\NP))/NP 	 3 	 quarter in
8 	 6 	 NP[nb]/N 	 1 	 quarter the
8 	 7 	 N/N 	 1 	 quarter third
<\s>
<s id="wsj_1594.2"> 30
1 	 0 	 N/N 	 1 	 houses Medical-supply
1 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 houses are
1 	 3 	 (S[pss]\NP)/(S[to]\NP) 	 1 	 houses expected <XB>
1 	 5 	 (S[b]\NP)/NP 	 1 	 houses report <XB>
2 	 29 	 (S[dcl]\S[dcl])\NP 	 1 	 are say
3 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 expected are
3 	 19 	 ((S\NP)\(S\NP))/NP 	 2 	 expected despite
4 	 3 	 (S[pss]\NP)/(S[to]\NP) 	 2 	 to expected
5 	 4 	 (S[to]\NP)/(S[b]\NP) 	 2 	 report to
7 	 5 	 (S[b]\NP)/NP 	 2 	 increases report
7 	 6 	 N/N 	 1 	 increases earnings
7 	 8 	 (NP\NP)/NP 	 1 	 increases of
7 	 14 	 (NP\NP)/NP 	 1 	 increases for
10 	 9 	 (N/N)/(N/N) 	 2 	 15 about
11 	 8 	 (NP\NP)/NP 	 2 	 % of
11 	 10 	 N/N 	 1 	 % 15
11 	 12 	 (NP\NP)/NP 	 1 	 % on
13 	 12 	 (NP\NP)/NP 	 2 	 average on
17 	 14 	 (NP\NP)/NP 	 2 	 quarter for
17 	 15 	 NP[nb]/N 	 1 	 quarter the
17 	 16 	 N/N 	 1 	 quarter third
21 	 19 	 ((S\NP)\(S\NP))/NP 	 3 	 increases despite
21 	 20 	 N/N 	 1 	 increases sales
21 	 22 	 (NP\NP)/NP 	 1 	 increases of
23 	 24 	 ((N/N)/(N/N))\(S[adj]\NP) 	 3 	 less than
25 	 24 	 ((N/N)/(N/N))\(S[adj]\NP) 	 2 	 10 than
26 	 22 	 (NP\NP)/NP 	 2 	 % of
26 	 25 	 N/N 	 1 	 % 10
28 	 29 	 (S[dcl]\S[dcl])\NP 	 2 	 analysts say
<\s>
<s id="wsj_1594.3"> 25
1 	 0 	 (S[to]\NP)/(S[b]\NP) 	 2 	 offset To
4 	 1 	 (S[b]\NP)/NP 	 2 	 growth offset
4 	 2 	 N/N 	 1 	 growth sluggish
4 	 3 	 N/N 	 1 	 growth sales
6 	 7 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 companies have
6 	 9 	 (S[ng]\NP)/NP 	 1 	 companies cutting <XB>
6 	 17 	 (S[ng]\NP)/NP 	 1 	 companies slowing <XU>
8 	 7 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been have
9 	 8 	 (S[pt]\NP)/(S[ng]\NP) 	 2 	 cutting been
9 	 13 	 ((S\NP)\(S\NP))/NP 	 2 	 cutting through
10 	 9 	 (S[ng]\NP)/NP 	 2 	 staff cutting
13 	 12 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 through mostly
14 	 13 	 ((S\NP)\(S\NP))/NP 	 3 	 attrition through
17 	 8 	 (S[pt]\NP)/(S[ng]\NP) 	 2 	 slowing been
19 	 17 	 (S[ng]\NP)/NP 	 2 	 growth slowing
19 	 18 	 NP[nb]/N 	 1 	 growth the
19 	 20 	 (NP\NP)/NP 	 1 	 growth in
21 	 20 	 (NP\NP)/NP 	 2 	 research in
24 	 20 	 (NP\NP)/NP 	 2 	 spending in
24 	 23 	 N/N 	 1 	 spending development
<\s>
<s id="wsj_1594.4"> 23
1 	 0 	 N/N 	 1 	 growth Sales
1 	 2 	 (NP\NP)/NP 	 1 	 growth in
1 	 5 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 growth was
1 	 6 	 S[pss]\NP 	 1 	 growth slowed <XB>
4 	 2 	 (NP\NP)/NP 	 2 	 quarter in
4 	 3 	 NP[nb]/N 	 1 	 quarter the
6 	 5 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 slowed was
6 	 7 	 ((S\NP)\(S\NP))/NP 	 2 	 slowed by
9 	 7 	 ((S\NP)\(S\NP))/NP 	 3 	 pressure by
9 	 8 	 N/N 	 1 	 pressure mounting
9 	 10 	 (NP\NP)/NP 	 1 	 pressure from
11 	 10 	 (NP\NP)/NP 	 2 	 groups from
11 	 12 	 (NP\NP)/NP 	 1 	 groups of
11 	 16 	 (NP\NP)/NP 	 1 	 groups as
13 	 12 	 (NP\NP)/NP 	 2 	 buyers of
16 	 15 	 (NP\NP)/(NP\NP) 	 2 	 as such
17 	 16 	 (NP\NP)/NP 	 2 	 hospitals as
20 	 19 	 (S[to]\NP)/(S[b]\NP) 	 2 	 hold to
20 	 21 	 (S\NP)\(S\NP) 	 2 	 hold down
22 	 20 	 (S[b]\NP)/NP 	 2 	 prices hold
<\s>
<s id="wsj_1594.5"> 16
0 	 1 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 Suppliers were
0 	 3 	 S[pss]\NP 	 1 	 Suppliers hurt <XB>
1 	 2 	 (S\NP)\(S\NP) 	 2 	 were also
3 	 1 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 hurt were
3 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 hurt by
8 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 dollar by
8 	 5 	 NP[nb]/N 	 1 	 dollar the
8 	 6 	 N/N 	 1 	 dollar stronger
8 	 7 	 N/N 	 1 	 dollar U.S.
8 	 10 	 (NP\NP)/(S[dcl]\NP) 	 1 	 dollar which
8 	 11 	 ((S[dcl]\NP)/(S[adj]\NP))/NP 	 1 	 dollar makes <XB>
11 	 10 	 (NP\NP)/(S[dcl]\NP) 	 2 	 makes which
12 	 11 	 ((S[dcl]\NP)/(S[adj]\NP))/NP 	 3 	 sales makes
12 	 13 	 NP\NP 	 1 	 sales abroad
12 	 15 	 S[adj]\NP 	 1 	 sales difficult <XB>
15 	 11 	 ((S[dcl]\NP)/(S[adj]\NP))/NP 	 2 	 difficult makes
15 	 14 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 difficult more
<\s>
<s id="wsj_1594.6"> 8
2 	 0 	 (S/S)/NP 	 2 	 cases In
2 	 1 	 NP[nb]/N 	 1 	 cases some
4 	 5 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 competition has
4 	 6 	 (S[pt]\NP)/NP 	 1 	 competition squeezed <XB>
5 	 0 	 (S/S)/NP 	 1 	 has In
6 	 5 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 squeezed has
7 	 6 	 (S[pt]\NP)/NP 	 2 	 margins squeezed
<\s>
<s id="wsj_1594.7"> 21
4 	 0 	 N/N 	 1 	 Co. Becton
4 	 2 	 N/N 	 1 	 Co. Dickinson
4 	 3 	 N/N 	 1 	 Co. &
4 	 9 	 (S[dcl]\NP)/NP 	 1 	 Co. faces
7 	 6 	 ((S\NP)/(S\NP))/NP 	 3 	 example for
9 	 6 	 ((S\NP)/(S\NP))/NP 	 2 	 faces for
11 	 9 	 (S[dcl]\NP)/NP 	 2 	 competition faces
11 	 10 	 N/N 	 1 	 competition stiff
11 	 12 	 (NP\NP)/NP 	 1 	 competition from
11 	 16 	 (NP\NP)/NP 	 1 	 competition in
15 	 12 	 (NP\NP)/NP 	 2 	 supplier from
15 	 13 	 NP[nb]/N 	 1 	 supplier a
15 	 14 	 N/N 	 1 	 supplier Japanese
20 	 16 	 (NP\NP)/NP 	 2 	 market in
20 	 17 	 NP[nb]/N 	 1 	 market the
20 	 18 	 N/N 	 1 	 market important
20 	 19 	 N/N 	 1 	 market syringe
<\s>
<s id="wsj_1594.8"> 43
4 	 1 	 (N/N)/(N/N) 	 2 	 N.J. Franklin
4 	 2 	 (N/N)/(N/N) 	 2 	 N.J. Lakes
6 	 0 	 NP[nb]/N 	 1 	 company The
6 	 4 	 N/N 	 1 	 company N.J.
6 	 7 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 company is
6 	 8 	 (S[pss]\NP)/(S[to]\NP) 	 1 	 company expected <XB>
6 	 10 	 (S[b]\NP)/NP 	 1 	 company report <XB>
6 	 22 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 company should <XU>
6 	 24 	 (S[b]\NP)/NP 	 1 	 company maintain <XU>
7 	 31 	 (S[dcl]\S[dcl])/NP 	 1 	 is says
8 	 7 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 expected is
9 	 8 	 (S[pss]\NP)/(S[to]\NP) 	 2 	 to expected
10 	 9 	 (S[to]\NP)/(S[b]\NP) 	 2 	 report to
12 	 10 	 (S[b]\NP)/NP 	 2 	 growth report
12 	 11 	 N/N 	 1 	 growth sales
12 	 13 	 (NP\NP)/NP 	 1 	 growth of
16 	 13 	 (NP\NP)/NP 	 2 	 % of
16 	 14 	 N/N 	 1 	 % only
16 	 15 	 N/N 	 1 	 % 5
16 	 17 	 (N\N)/N 	 1 	 % to
19 	 17 	 (N\N)/N 	 2 	 % to
19 	 18 	 N/N 	 1 	 % 6
22 	 23 	 (S\NP)\(S\NP) 	 2 	 should still
22 	 31 	 (S[dcl]\S[dcl])/NP 	 1 	 should says
24 	 22 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 maintain should
26 	 24 	 (S[b]\NP)/NP 	 2 	 growth maintain
26 	 25 	 N/N 	 1 	 growth earnings
26 	 27 	 (NP\NP)/NP 	 1 	 growth of
29 	 27 	 (NP\NP)/NP 	 2 	 % of
29 	 28 	 N/N 	 1 	 % 10
34 	 31 	 (S[dcl]\S[dcl])/NP 	 2 	 Fuller says
34 	 32 	 N/N 	 1 	 Fuller Jerry
34 	 33 	 N/N 	 1 	 Fuller E.
37 	 31 	 (S[dcl]\S[dcl])/NP 	 2 	 analyst says
37 	 36 	 NP[nb]/N 	 1 	 analyst an
37 	 38 	 (NP\NP)/NP 	 1 	 analyst with
42 	 38 	 (NP\NP)/NP 	 2 	 Inc with
42 	 39 	 N/N 	 1 	 Inc Duff
42 	 40 	 N/N 	 1 	 Inc &
42 	 41 	 N/N 	 1 	 Inc Phelps
<\s>
<s id="wsj_1594.9"> 44
2 	 0 	 (S/S)/NP 	 2 	 first Among
2 	 1 	 NP[nb]/N 	 1 	 first the
2 	 3 	 (NP\NP)/NP 	 1 	 first of
5 	 3 	 (NP\NP)/NP 	 2 	 group of
5 	 4 	 NP[nb]/N 	 1 	 group the
7 	 6 	 (S[to]\NP)/(S[b]\NP) 	 2 	 post to
8 	 7 	 (S[b]\NP)/NP 	 2 	 results post
11 	 10 	 N/N 	 1 	 Laboratories Abbott
11 	 12 	 (S[dcl]\NP)/S[dcl] 	 1 	 Laboratories said
12 	 0 	 (S/S)/NP 	 1 	 said Among
15 	 13 	 N/N 	 1 	 income third-quarter
15 	 14 	 N/N 	 1 	 income net
15 	 16 	 S[dcl]\NP 	 1 	 income jumped
16 	 12 	 (S[dcl]\NP)/S[dcl] 	 2 	 jumped said
16 	 18 	 (S\NP)\(S\NP) 	 2 	 jumped %
16 	 19 	 ((S\NP)\(S\NP))/NP 	 2 	 jumped to
16 	 30 	 ((S\NP)\(S\NP))/NP 	 2 	 jumped from
18 	 17 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 14
20 	 19 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
22 	 20 	 N/N[num] 	 1 	 million $
22 	 21 	 N/N 	 1 	 million 196
26 	 19 	 ((S\NP)\(S\NP))/NP 	 3 	 cents to
26 	 25 	 N/N 	 1 	 cents 88
26 	 27 	 (NP\NP)/N 	 1 	 cents a
28 	 27 	 (NP\NP)/N 	 2 	 share a
30 	 43 	 (((S\NP)\(S\NP))\((S\NP)\(S\NP)))\NP 	 3 	 from earlier
31 	 30 	 ((S\NP)\(S\NP))/NP 	 3 	 $ from
33 	 31 	 N/N[num] 	 1 	 million $
33 	 32 	 N/N 	 1 	 million 172
37 	 30 	 ((S\NP)\(S\NP))/NP 	 3 	 cents from
37 	 36 	 N/N 	 1 	 cents 76
37 	 38 	 (NP\NP)/N 	 1 	 cents a
39 	 38 	 (NP\NP)/N 	 2 	 share a
42 	 41 	 NP[nb]/N 	 1 	 year a
42 	 43 	 (((S\NP)\(S\NP))\((S\NP)\(S\NP)))\NP 	 4 	 year earlier
<\s>
<s id="wsj_1594.10"> 23
0 	 1 	 (NP\NP)/NP 	 1 	 Sales for
0 	 12 	 S[dcl]\NP 	 1 	 Sales rose
3 	 1 	 (NP\NP)/NP 	 2 	 company for
3 	 2 	 NP[nb]/N 	 1 	 company the
3 	 5 	 S[pss]\NP 	 1 	 company based <XB>
5 	 6 	 ((S\NP)\(S\NP))/NP 	 2 	 based in
8 	 6 	 ((S\NP)\(S\NP))/NP 	 3 	 Park in
8 	 7 	 N/N 	 1 	 Park Abbott
10 	 6 	 ((S\NP)\(S\NP))/NP 	 3 	 Ill. in
12 	 14 	 (S\NP)\(S\NP) 	 2 	 rose %
12 	 15 	 ((S\NP)\(S\NP))/NP 	 2 	 rose to
12 	 19 	 ((S\NP)\(S\NP))/NP 	 2 	 rose from
14 	 13 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 8.3
16 	 15 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
18 	 16 	 N/N[num] 	 1 	 billion $
18 	 17 	 N/N 	 1 	 billion 1.31
20 	 19 	 ((S\NP)\(S\NP))/NP 	 3 	 $ from
22 	 20 	 N/N[num] 	 1 	 billion $
22 	 21 	 N/N 	 1 	 billion 1.21
<\s>
<s id="wsj_1594.11"> 38
2 	 0 	 N/N 	 1 	 Inc. Baxter
2 	 1 	 N/N 	 1 	 Inc. International
2 	 4 	 (S[dcl]\NP)/S[dcl] 	 1 	 Inc. reported
4 	 3 	 (S\NP)/(S\NP) 	 2 	 reported yesterday
5 	 6 	 S[dcl]\NP 	 1 	 net climbed
6 	 4 	 (S[dcl]\NP)/S[dcl] 	 2 	 climbed reported
6 	 8 	 (S\NP)\(S\NP) 	 2 	 climbed %
6 	 9 	 ((S\NP)\(S\NP))/NP 	 2 	 climbed in
6 	 13 	 ((S\NP)\(S\NP))/NP 	 2 	 climbed to
6 	 24 	 ((S\NP)\(S\NP))/NP 	 2 	 climbed from
8 	 7 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 20
12 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 period in
12 	 10 	 NP[nb]/N 	 1 	 period the
12 	 11 	 N/N 	 1 	 period third
14 	 13 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
16 	 14 	 N/N[num] 	 1 	 million $
16 	 15 	 N/N 	 1 	 million 102
20 	 13 	 ((S\NP)\(S\NP))/NP 	 3 	 cents to
20 	 19 	 N/N 	 1 	 cents 34
20 	 21 	 (NP\NP)/N 	 1 	 cents a
22 	 21 	 (NP\NP)/N 	 2 	 share a
24 	 37 	 (((S\NP)\(S\NP))\((S\NP)\(S\NP)))\NP 	 3 	 from earlier
25 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 $ from
27 	 25 	 N/N[num] 	 1 	 million $
27 	 26 	 N/N 	 1 	 million 85
31 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 cents from
31 	 30 	 N/N 	 1 	 cents 28
31 	 32 	 (NP\NP)/N 	 1 	 cents a
33 	 32 	 (NP\NP)/N 	 2 	 share a
36 	 35 	 NP[nb]/N 	 1 	 year a
36 	 37 	 (((S\NP)\(S\NP))\((S\NP)\(S\NP)))\NP 	 4 	 year earlier
<\s>
<s id="wsj_1594.12"> 19
0 	 1 	 (NP\NP)/NP 	 1 	 Sales for
0 	 8 	 S[dcl]\NP 	 1 	 Sales rose
5 	 3 	 (N/N)/(N/N) 	 2 	 Ill. Deerfield
7 	 1 	 (NP\NP)/NP 	 2 	 company for
7 	 2 	 NP[nb]/N 	 1 	 company the
7 	 5 	 N/N 	 1 	 company Ill.
8 	 10 	 (S\NP)\(S\NP) 	 2 	 rose %
8 	 11 	 ((S\NP)\(S\NP))/NP 	 2 	 rose to
8 	 15 	 ((S\NP)\(S\NP))/NP 	 2 	 rose from
10 	 9 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 5.8
12 	 11 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
14 	 12 	 N/N[num] 	 1 	 billion $
14 	 13 	 N/N 	 1 	 billion 1.81
16 	 15 	 ((S\NP)\(S\NP))/NP 	 3 	 $ from
18 	 16 	 N/N[num] 	 1 	 billion $
18 	 17 	 N/N 	 1 	 billion 1.71
<\s>
<s id="wsj_1594.13"> 9
2 	 1 	 (N/N)/(N/N) 	 2 	 every not
3 	 2 	 N/N 	 1 	 company every
3 	 4 	 (S[dcl]\NP)/(S[to]\NP) 	 1 	 company expects
3 	 6 	 (S[b]\NP)/NP 	 1 	 company report <XB>
4 	 0 	 S/S 	 1 	 expects But
5 	 4 	 (S[dcl]\NP)/(S[to]\NP) 	 2 	 to expects
6 	 5 	 (S[to]\NP)/(S[b]\NP) 	 2 	 report to
8 	 6 	 (S[b]\NP)/NP 	 2 	 earnings report
8 	 7 	 N/N 	 1 	 earnings increased
<\s>
<s id="wsj_1594.14"> 35
2 	 0 	 N/N 	 1 	 Inc. C.R.
2 	 1 	 N/N 	 1 	 Inc. Bard
2 	 4 	 (S[dcl]\NP)/S[dcl] 	 1 	 Inc. said
4 	 3 	 (S\NP)/(S\NP) 	 2 	 said yesterday
6 	 5 	 N/N 	 1 	 net third-quarter
6 	 7 	 S[dcl]\NP 	 1 	 net plunged
7 	 4 	 (S[dcl]\NP)/S[dcl] 	 2 	 plunged said
7 	 9 	 (S\NP)\(S\NP) 	 2 	 plunged %
7 	 10 	 ((S\NP)\(S\NP))/NP 	 2 	 plunged to
7 	 21 	 ((S\NP)\(S\NP))/NP 	 2 	 plunged from
9 	 8 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 51
11 	 10 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
13 	 11 	 N/N[num] 	 1 	 million $
13 	 12 	 N/N 	 1 	 million 9.9
17 	 10 	 ((S\NP)\(S\NP))/NP 	 3 	 cents to
17 	 16 	 N/N 	 1 	 cents 18
17 	 18 	 (NP\NP)/N 	 1 	 cents a
19 	 18 	 (NP\NP)/N 	 2 	 share a
21 	 34 	 (((S\NP)\(S\NP))\((S\NP)\(S\NP)))\NP 	 3 	 from earlier
22 	 21 	 ((S\NP)\(S\NP))/NP 	 3 	 $ from
24 	 22 	 N/N[num] 	 1 	 million $
24 	 23 	 N/N 	 1 	 million 20
28 	 21 	 ((S\NP)\(S\NP))/NP 	 3 	 cents from
28 	 27 	 N/N 	 1 	 cents 35
28 	 29 	 (NP\NP)/N 	 1 	 cents a
30 	 29 	 (NP\NP)/N 	 2 	 share a
33 	 32 	 NP[nb]/N 	 1 	 year a
33 	 34 	 (((S\NP)\(S\NP))\((S\NP)\(S\NP)))\NP 	 4 	 year earlier
<\s>
<s id="wsj_1594.15"> 12
0 	 1 	 S[dcl]\NP 	 1 	 Sales fell
1 	 3 	 (S\NP)\(S\NP) 	 2 	 fell %
1 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 fell to
1 	 8 	 ((S\NP)\(S\NP))/NP 	 2 	 fell from
3 	 2 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 1.2
5 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
7 	 5 	 N/N[num] 	 1 	 million $
7 	 6 	 N/N 	 1 	 million 190.1
9 	 8 	 ((S\NP)\(S\NP))/NP 	 3 	 $ from
11 	 9 	 N/N[num] 	 1 	 million $
11 	 10 	 N/N 	 1 	 million 192.5
<\s>
<s id="wsj_1594.16"> 26
4 	 1 	 (N/N)/(N/N) 	 2 	 N.J. Murray
4 	 2 	 (N/N)/(N/N) 	 2 	 N.J. Hill
6 	 0 	 NP[nb]/N 	 1 	 company The
6 	 4 	 N/N 	 1 	 company N.J.
6 	 7 	 (S[dcl]\NP)/S[dcl] 	 1 	 company said
9 	 8 	 N/N 	 1 	 earnings full-year
9 	 10 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 earnings may
9 	 12 	 (S[adj]\NP)/NP 	 1 	 earnings off <XB>
10 	 7 	 (S[dcl]\NP)/S[dcl] 	 2 	 may said
11 	 10 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be may
11 	 17 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 be because
12 	 11 	 (S[b]\NP)/(S[adj]\NP) 	 2 	 off be
14 	 12 	 (S[adj]\NP)/NP 	 2 	 cents off
14 	 13 	 N/N 	 1 	 cents 33
14 	 15 	 (NP\NP)/N 	 1 	 cents a
16 	 15 	 (NP\NP)/N 	 2 	 share a
19 	 18 	 NP[nb]/N 	 1 	 company the
19 	 20 	 ((S[dcl]\NP)/PP)/NP 	 1 	 company removed
20 	 17 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 removed because
22 	 20 	 ((S[dcl]\NP)/PP)/NP 	 3 	 catheter removed
22 	 21 	 NP[nb]/N 	 1 	 catheter a
23 	 20 	 ((S[dcl]\NP)/PP)/NP 	 2 	 from removed
25 	 23 	 PP/NP 	 1 	 market from
25 	 24 	 NP[nb]/N 	 1 	 market the
<\s>
<s id="wsj_1594.17"> 10
1 	 0 	 (S/S)/NP 	 2 	 1988 In
4 	 3 	 NP[nb]/N 	 1 	 company the
4 	 5 	 (S[dcl]\NP)/NP 	 1 	 company earned
5 	 0 	 (S/S)/NP 	 1 	 earned In
6 	 5 	 (S[dcl]\NP)/NP 	 2 	 $ earned
6 	 8 	 (NP\NP)/N 	 1 	 $ a
7 	 6 	 N/N[num] 	 1 	 1.38 $
9 	 8 	 (NP\NP)/N 	 2 	 share a
<\s>
<s id="wsj_1594.18"> 13
1 	 0 	 NP[nb]/N 	 1 	 Food The
1 	 5 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 Food had
1 	 6 	 (S[pt]\NP)/NP 	 1 	 Food raised <XB>
4 	 0 	 NP[nb]/N 	 1 	 Administration The
4 	 3 	 N/N 	 1 	 Administration Drug
4 	 5 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 Administration had
4 	 6 	 (S[pt]\NP)/NP 	 1 	 Administration raised <XB>
6 	 5 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 raised had
7 	 6 	 (S[pt]\NP)/NP 	 2 	 questions raised
7 	 8 	 (NP\NP)/NP 	 1 	 questions about
10 	 9 	 NP[nb]/N 	 1 	 device the
10 	 11 	 (NP[nb]/N)\NP 	 2 	 device 's
12 	 8 	 (NP\NP)/NP 	 2 	 design about
12 	 11 	 (NP[nb]/N)\NP 	 1 	 design 's
<\s>
<s id="wsj_1594.19"> 18
1 	 0 	 NP[nb]/N 	 1 	 analysts Some
1 	 2 	 (S[dcl]\NP)/S[em] 	 1 	 analysts add
3 	 2 	 (S[dcl]\NP)/S[em] 	 2 	 that add
5 	 4 	 N/N 	 1 	 pressures third-party
5 	 7 	 (S[b]\NP)/NP 	 1 	 pressures reduce <XB>
5 	 10 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 pressures will
5 	 11 	 (S[b]\NP)/(S[to]\NP) 	 1 	 pressures continue <XB>
5 	 13 	 (S[b]\NP)/NP 	 1 	 pressures bedevil <XB>
7 	 6 	 (S[to]\NP)/(S[b]\NP) 	 2 	 reduce to
9 	 7 	 (S[b]\NP)/NP 	 2 	 costs reduce
9 	 8 	 N/N 	 1 	 costs health
10 	 3 	 S[em]/S[dcl] 	 1 	 will that
11 	 10 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 continue will
12 	 11 	 (S[b]\NP)/(S[to]\NP) 	 2 	 to continue
13 	 12 	 (S[to]\NP)/(S[b]\NP) 	 2 	 bedevil to
14 	 15 	 (NP[nb]/N)\NP 	 2 	 companies '
17 	 13 	 (S[b]\NP)/NP 	 2 	 lines bedevil
17 	 15 	 (NP[nb]/N)\NP 	 1 	 lines '
17 	 16 	 N/N 	 1 	 lines bottom
<\s>
<s id="wsj_1594.20"> 27
1 	 0 	 N/N 	 1 	 speculation Takeover
1 	 3 	 (NP\NP)/(S[dcl]\NP) 	 1 	 speculation which
1 	 4 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 speculation has <XB>
1 	 6 	 (S[ng]\NP)/NP 	 1 	 speculation buoying <XB>
1 	 12 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 speculation may
1 	 14 	 S[b]\NP 	 1 	 speculation ease <XB>
4 	 3 	 (NP\NP)/(S[dcl]\NP) 	 2 	 has which
5 	 4 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been has
6 	 5 	 (S[pt]\NP)/(S[ng]\NP) 	 2 	 buoying been
7 	 6 	 (S[ng]\NP)/NP 	 2 	 stocks buoying
7 	 8 	 (NP\NP)/NP 	 1 	 stocks of
10 	 8 	 (NP\NP)/NP 	 2 	 houses of
10 	 9 	 N/N 	 1 	 houses supply
12 	 13 	 (S\NP)\(S\NP) 	 2 	 may also
12 	 16 	 (S[dcl]\S[dcl])/NP 	 1 	 may says
14 	 12 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 ease may
18 	 16 	 (S[dcl]\S[dcl])/NP 	 2 	 Sidoti says
18 	 17 	 N/N 	 1 	 Sidoti Peter
21 	 16 	 (S[dcl]\S[dcl])/NP 	 2 	 analyst says
21 	 20 	 NP[nb]/N 	 1 	 analyst an
21 	 22 	 (NP\NP)/NP 	 1 	 analyst with
26 	 22 	 (NP\NP)/NP 	 2 	 Inc with
26 	 23 	 N/N 	 1 	 Inc Drexel
26 	 24 	 N/N 	 1 	 Inc Burnham
26 	 25 	 N/N 	 1 	 Inc Lambert
<\s>
<s id="wsj_1594.21"> 18
1 	 2 	 S[dcl]\NP 	 1 	 that wanes
2 	 0 	 (S/S)/S[dcl] 	 2 	 wanes As
4 	 5 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 you 're
4 	 8 	 (S[b]\NP)/S[dcl] 	 1 	 you see <XB>
5 	 0 	 (S/S)/S[dcl] 	 1 	 're As
5 	 17 	 (S[dcl]\S[dcl])\NP 	 1 	 're says
6 	 5 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 going 're
7 	 6 	 (S[ng]\NP)/(S[to]\NP) 	 2 	 to going
8 	 7 	 (S[to]\NP)/(S[b]\NP) 	 2 	 see to
10 	 9 	 NP[nb]/N 	 1 	 stocks the
10 	 12 	 S[dcl]\NP 	 1 	 stocks wane
12 	 8 	 (S[b]\NP)/S[dcl] 	 2 	 wane see
12 	 11 	 (S\NP)/(S\NP) 	 2 	 wane probably
12 	 14 	 (S\NP)\(S\NP) 	 2 	 wane well
14 	 13 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 well as
16 	 17 	 (S[dcl]\S[dcl])\NP 	 2 	 he says
<\s>
<s id="wsj_1594.22"> 9
1 	 0 	 N/N 	 1 	 companies Hospitals
1 	 5 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 companies are
1 	 6 	 (S[ng]\NP)/NP 	 1 	 companies reporting <XB>
5 	 3 	 (S\NP)/(S\NP) 	 2 	 are meanwhile
6 	 5 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 reporting are
8 	 6 	 (S[ng]\NP)/NP 	 2 	 earnings reporting
8 	 7 	 N/N 	 1 	 earnings improved
<\s>
<s id="wsj_1594.23"> 54
0 	 1 	 ((S\NP)\(S\NP))/NP 	 2 	 Bolstered by
3 	 1 	 ((S\NP)\(S\NP))/NP 	 3 	 performances by
3 	 2 	 N/N 	 1 	 performances strong
3 	 4 	 (NP\NP)/NP 	 1 	 performances by
7 	 4 	 (NP\NP)/NP 	 2 	 hospitals by
7 	 5 	 NP[nb]/N 	 1 	 hospitals its
7 	 6 	 N/N 	 1 	 hospitals psychiatric
12 	 9 	 N/N 	 1 	 Inc. National
12 	 10 	 N/N 	 1 	 Inc. Medical
12 	 11 	 N/N 	 1 	 Inc. Enterprises
12 	 15 	 NP\NP 	 1 	 Inc. Angeles
12 	 17 	 (S[dcl]\NP)/NP 	 1 	 Inc. reported
15 	 14 	 (NP\NP)/(NP\NP) 	 2 	 Angeles Los
19 	 17 	 (S[dcl]\NP)/NP 	 2 	 income reported
19 	 18 	 N/N 	 1 	 income net
19 	 20 	 (NP\NP)/NP 	 1 	 income of
19 	 31 	 (NP\NP)/NP 	 1 	 income for
19 	 39 	 (NP\NP)/PP 	 1 	 income up
21 	 20 	 (NP\NP)/NP 	 2 	 $ of
23 	 21 	 N/N[num] 	 1 	 million $
23 	 22 	 N/N 	 1 	 million 50
27 	 20 	 (NP\NP)/NP 	 2 	 cents of
27 	 26 	 N/N 	 1 	 cents 65
27 	 28 	 (NP\NP)/N 	 1 	 cents a
29 	 28 	 (NP\NP)/N 	 2 	 share a
34 	 31 	 (NP\NP)/NP 	 2 	 quarter for
34 	 32 	 NP[nb]/N 	 1 	 quarter the
34 	 33 	 N/N 	 1 	 quarter first
34 	 35 	 S[pss]\NP 	 1 	 quarter ended <XB>
35 	 36 	 ((S\NP)\(S\NP))/N[num] 	 2 	 ended Aug.
37 	 36 	 ((S\NP)\(S\NP))/N[num] 	 3 	 31 Aug.
40 	 39 	 (NP\NP)/PP 	 2 	 from up
40 	 53 	 (PP\PP)\NP 	 1 	 from earlier
41 	 40 	 PP/NP 	 1 	 $ from
43 	 41 	 N/N[num] 	 1 	 million $
43 	 42 	 N/N 	 1 	 million 41
47 	 40 	 PP/NP 	 1 	 cents from
47 	 46 	 N/N 	 1 	 cents 56
47 	 48 	 (NP\NP)/N 	 1 	 cents a
49 	 48 	 (NP\NP)/N 	 2 	 share a
52 	 51 	 NP[nb]/N 	 1 	 year a
52 	 53 	 (PP\PP)\NP 	 2 	 year earlier
<\s>
<s id="wsj_1594.24"> 45
1 	 0 	 N/N 	 1 	 Inc. Humana
1 	 3 	 NP\NP 	 1 	 Inc. Louisville
1 	 5 	 NP\NP 	 1 	 Inc. Ky. <XU>
1 	 8 	 (S[dcl]\NP)/NP 	 1 	 Inc. reported
8 	 7 	 (S\NP)/(S\NP) 	 2 	 reported also
10 	 8 	 (S[dcl]\NP)/NP 	 2 	 results reported
10 	 9 	 N/N 	 1 	 results favorable
10 	 12 	 (NP\NP)/NP 	 1 	 results with
14 	 12 	 (NP\NP)/NP 	 2 	 income with
14 	 13 	 N/N 	 1 	 income net
14 	 15 	 (NP\NP)/NP 	 1 	 income of
14 	 24 	 (NP\NP)/NP 	 1 	 income in
14 	 32 	 (NP\NP)/PP 	 1 	 income up
16 	 15 	 (NP\NP)/NP 	 2 	 $ of
18 	 16 	 N/N[num] 	 1 	 million $
18 	 17 	 N/N 	 1 	 million 66.7
22 	 15 	 (NP\NP)/NP 	 2 	 cents of
22 	 21 	 N/N 	 1 	 cents 66
27 	 24 	 (NP\NP)/NP 	 2 	 quarter in
27 	 25 	 NP[nb]/N 	 1 	 quarter the
27 	 26 	 N/N 	 1 	 quarter fourth
27 	 28 	 S[pss]\NP 	 1 	 quarter ended <XB>
28 	 29 	 ((S\NP)\(S\NP))/N[num] 	 2 	 ended Aug.
30 	 29 	 ((S\NP)\(S\NP))/N[num] 	 3 	 31 Aug.
33 	 32 	 (NP\NP)/PP 	 2 	 from up
33 	 44 	 (PP\PP)\NP 	 1 	 from earlier
34 	 33 	 PP/NP 	 1 	 $ from
36 	 34 	 N/N[num] 	 1 	 million $
36 	 35 	 N/N 	 1 	 million 58.2
40 	 33 	 PP/NP 	 1 	 cents from
40 	 39 	 N/N 	 1 	 cents 59
43 	 42 	 NP[nb]/N 	 1 	 year a
43 	 44 	 (PP\PP)\NP 	 2 	 year earlier
<\s>
<s id="wsj_1594.25"> 17
0 	 1 	 (S[dcl]\NP)/S[dcl] 	 1 	 Analysts say
3 	 2 	 NP[nb]/N 	 1 	 handful the
3 	 4 	 (NP\NP)/NP 	 1 	 handful of
3 	 7 	 (NP\NP)/(S[dcl]\NP) 	 1 	 handful that
3 	 8 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 handful are <XB>
3 	 11 	 S[pss]\NP 	 1 	 handful traded <XB>
3 	 12 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 handful are
3 	 13 	 (S[ng]\NP)/PP 	 1 	 handful benefiting <XB>
6 	 4 	 (NP\NP)/NP 	 2 	 companies of
6 	 5 	 N/N 	 1 	 companies hospital
8 	 7 	 (NP\NP)/(S[dcl]\NP) 	 2 	 are that
8 	 9 	 (S\NP)\(S\NP) 	 2 	 are still
11 	 8 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 traded are
11 	 10 	 (S\NP)/(S\NP) 	 2 	 traded publicly
12 	 1 	 (S[dcl]\NP)/S[dcl] 	 2 	 are say
13 	 12 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 benefiting are
14 	 13 	 (S[ng]\NP)/PP 	 2 	 from benefiting
16 	 14 	 PP/NP 	 1 	 trends from
16 	 15 	 N/N 	 1 	 trends several
<\s>
<s id="wsj_1594.26"> 13
1 	 0 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 important Most
5 	 3 	 N/N 	 1 	 rates hospital
5 	 4 	 N/N 	 1 	 rates admission
5 	 6 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 rates are
5 	 7 	 S[ng]\NP 	 1 	 rates stabilizing <XB>
7 	 6 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 stabilizing are
7 	 8 	 ((S\NP)\(S\NP))/NP 	 2 	 stabilizing after
10 	 8 	 ((S\NP)\(S\NP))/NP 	 3 	 years after
10 	 9 	 N/N 	 1 	 years several
10 	 11 	 (NP\NP)/NP 	 1 	 years of
12 	 11 	 (NP\NP)/NP 	 2 	 decline of
<\s>
<s id="wsj_1594.27"> 18
2 	 3 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 companies have
2 	 4 	 (S[pt]\NP)/NP 	 1 	 companies sold <XB>
2 	 14 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 companies have <XU>
2 	 15 	 (S[pt]\NP)/NP 	 1 	 companies completed <XU>
3 	 0 	 S/S 	 1 	 have Moreover
4 	 3 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 sold have
4 	 5 	 (S\NP)\(S\NP) 	 2 	 sold off
6 	 4 	 (S[pt]\NP)/NP 	 2 	 many sold
6 	 7 	 (NP\NP)/NP 	 1 	 many of
12 	 7 	 (NP\NP)/NP 	 2 	 hospitals of
12 	 8 	 NP[nb]/N 	 1 	 hospitals their
12 	 9 	 N/N 	 1 	 hospitals smaller
12 	 11 	 N/N 	 1 	 hospitals less-profitable
14 	 0 	 S/S 	 1 	 have Moreover
15 	 14 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 completed have
17 	 15 	 (S[pt]\NP)/NP 	 2 	 restructurings completed
17 	 16 	 N/N 	 1 	 restructurings painful
<\s>
<s id="wsj_1594.28"> 22
0 	 1 	 (NP[nb]/N)\NP 	 2 	 Humana 's
2 	 1 	 (NP[nb]/N)\NP 	 1 	 revenues 's
2 	 7 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 revenues are
2 	 8 	 (S[ng]\NP)/(S[pss]\NP) 	 1 	 revenues being <XB>
2 	 9 	 S[pss]\NP 	 1 	 revenues boosted <XB>
5 	 4 	 ((S\NP)/(S\NP))/NP 	 3 	 example for
7 	 4 	 ((S\NP)/(S\NP))/NP 	 2 	 are for
8 	 7 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 being are
9 	 8 	 (S[ng]\NP)/(S[pss]\NP) 	 2 	 boosted being
9 	 10 	 ((S\NP)\(S\NP))/NP 	 2 	 boosted by
12 	 10 	 ((S\NP)\(S\NP))/NP 	 3 	 increases by
12 	 11 	 N/N 	 1 	 increases large
12 	 13 	 (NP\NP)/NP 	 1 	 increases in
14 	 13 	 (NP\NP)/NP 	 2 	 enrollments in
14 	 15 	 (NP\NP)/NP 	 1 	 enrollments in
17 	 16 	 NP[nb]/N 	 1 	 company the
17 	 18 	 (NP[nb]/N)\NP 	 2 	 company 's
21 	 15 	 (NP\NP)/NP 	 2 	 organizations in
21 	 18 	 (NP[nb]/N)\NP 	 1 	 organizations 's
21 	 19 	 N/N 	 1 	 organizations health
21 	 20 	 N/N 	 1 	 organizations maintenance
<\s>
<s id="wsj_1594.29"> 20
2 	 0 	 (S[dcl]/S[dcl])/NP 	 2 	 Richter Says
2 	 1 	 N/N 	 1 	 Richter Todd
5 	 0 	 (S[dcl]/S[dcl])/NP 	 2 	 analyst Says
5 	 4 	 NP[nb]/N 	 1 	 analyst an
5 	 6 	 (NP\NP)/NP 	 1 	 analyst with
9 	 6 	 (NP\NP)/NP 	 2 	 Reynolds with
9 	 7 	 N/N 	 1 	 Reynolds Dean
9 	 8 	 N/N 	 1 	 Reynolds Witter
12 	 11 	 NP[nb]/N 	 1 	 shakeout The
12 	 13 	 (NP\NP)/NP 	 1 	 shakeout in
12 	 18 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 shakeout is
12 	 19 	 S[adj]\NP 	 1 	 shakeout over <XB>
16 	 15 	 (N/N)/(N/N) 	 2 	 traded publicly
17 	 13 	 (NP\NP)/NP 	 2 	 companies in
17 	 14 	 NP[nb]/N 	 1 	 companies the
17 	 16 	 N/N 	 1 	 companies traded
18 	 0 	 (S[dcl]/S[dcl])/NP 	 1 	 is Says
19 	 18 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 over is
<\s>
